Immunoreactivity of 69-yr-old patient with T1bN0M0 TNBC.

Abstract

<p>(A) Hematoxylin and Eosin (H&E), (B) EGFR (>70%), (C) CK5/6 (>70%), (D) ER, (E) PR, (F) HER2, (G) Ki-67 (>60%), and (H) P53 (>90%). The patient was undergone BCT, had 3.8 event free survival and 22.8 months overall survival.</p